Literature DB >> 15609381

Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis.

H Lang1, G C Sotiropoulos, M Dömland, N R Frühauf, A Paul, J Hüsing, M Malagó, C E Broelsch.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) arising in normal liver parenchyma is rare and the outcome after hepatectomy is not well documented.
METHODS: Between June 1998 and September 2003, 33 patients without viral hepatitis underwent resection for HCC in a non-cirrhotic, non-fibrotic liver. Data were analysed with regard to operative details, pathological findings including completeness of resection, and outcome as measured by tumour recurrence and survival.
RESULTS: Twenty-three major hepatectomies and ten segmentectomies or bisegmentectomies were performed. After potentially curative resection, 19 of 29 patients were alive at a median follow-up of 25 months, with calculated 1- and 3-year survival rates of 87 and 50 per cent respectively. Survival was significantly better after resection of tumours without vascular invasion (3-year survival rate 89 versus 18 per cent; P = 0.024). Disseminated recurrence developed in nine of 29 patients, leading to death within 28 months of operation in all but one of the nine.
CONCLUSION: These data justify hepatic resection for HCC arising in non-cirrhotic, non-fibrotic liver without underlying viral hepatitis. Liver transplantation is rarely indicated because the outcome is good after resection of tumours without vascular infiltration, whereas vascular invasion is invariably associated with diffuse extrahepatic recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 15609381     DOI: 10.1002/bjs.4763

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

Review 1.  [Indications for transplantation and bridging procedures for primary hepatobiliary malignancies].

Authors:  J Mittler; S Heinrich; H Lang
Journal:  Chirurg       Date:  2018-11       Impact factor: 0.955

2.  Management of hepatocellular carcinoma: Enlightening the gray zones.

Authors:  Andrea Mancuso
Journal:  World J Hepatol       Date:  2013-06-27

3.  2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

4.  Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.

Authors:  Saleh A Alqahtani; Faisal M Sanai; Ashwaq Alolayan; Faisal Abaalkhail; Hamad Alsuhaibani; Mazen Hassanain; Waleed Alhazzani; Abdullah Alsuhaibani; Abdullah Algarni; Alejandro Forner; Richard S Finn; Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2020-10       Impact factor: 2.485

5.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

6.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

7.  Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

Authors:  D Gomez; S Farid; H Z Malik; A L Young; G J Toogood; J P A Lodge; K R Prasad
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

8.  Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors.

Authors:  Sicong Ma; Min Ding; Jiang Li; Tao Wang; Xingxing Qi; Yaoping Shi; Yanan Ming; Jiachang Chi; Zhi Wang; Xiaoyin Tang; Dan Cui; Yuan Zhang; Bo Zhai
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-20       Impact factor: 4.553

9.  Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse.

Authors:  Jean Lubrano; Emmanuel Huet; Basile Tsilividis; Arnaud François; Odile Goria; Ghassan Riachi; Michel Scotté
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

10.  Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.

Authors:  Young Chul Kim; Yun Hwan Kim; Soon Ho Um; Yeon Seok Seo; Eun Kyung Park; Sun Young Oh; You Mie Han; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.